Cargando…

Commentary: Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Saschenbrecker, Sandra, Zeng, Zitao, Dähnrich, Cornelia, Schlumberger, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639864/ https://www.ncbi.nlm.nih.gov/pubmed/36353646 http://dx.doi.org/10.3389/fimmu.2022.1050197

Ejemplares similares

Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
por: Ma, Lisha, et al.
Publicado: (2022)

Association of Interleukin-10 Genotypes and Anticyclic Citrullinated Peptide Antibodies with Rheumatoid Arthritis
por: Moghimi, Nasrin, et al.
Publicado: (2022)

Diagnostic value of anticyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis: association with extra-articular manifestations
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study
por: Reichert, Stefan, et al.
Publicado: (2015)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
por: Takahashi, Ryo, et al.
Publicado: (2014)

Combinations of Anticyclic Citrullinated Protein Antibody, Rheumatoid Factor, and Serum Calprotectin Positivity Are Associated With the Diagnosis of Rheumatoid Arthritis Within 3 Years
por: Bettner, Leah F., et al.
Publicado: (2021)

Serological Diagnosis of Autoimmune Bullous Skin Diseases
por: Saschenbrecker, Sandra, et al.
Publicado: (2019)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
por: Dähnrich, Cornelia, et al.
Publicado: (2019)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens
por: Fernandes-Cerqueira, Cátia, et al.
Publicado: (2015)

Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2020)

Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis
por: Bergstedt, Dylan T., et al.
Publicado: (2022)

Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019)

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2021)

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis
por: Li, Chun, et al.
Publicado: (2019)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
por: Díaz-Toscano, Miriam Lizette, et al.
Publicado: (2014)

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
por: Pruijn, Ger JM, et al.
Publicado: (2010)

The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis
por: Sieghart, Daniela, et al.
Publicado: (2023)

Anti-Cyclic Citrullinated Peptide Antibody Is Associated with Interstitial Lung Disease in Patients with Rheumatoid Arthritis
por: Yin, Yufeng, et al.
Publicado: (2014)

Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
por: Mewar, Devesh, et al.
Publicado: (2006)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients
por: Jearn, La-He, et al.
Publicado: (2010)

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
por: Viatte, Sebastien, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis
por: Abdul Wahab, Asrul, et al.
Publicado: (2013)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
por: Shibahara, Tomoya, et al.
Publicado: (2016)

Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis
por: Szarka, Eszter, et al.
Publicado: (2018)

Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis
por: Khatri, Sangita, et al.
Publicado: (2020)

Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?
por: Nogueira, Leonor, et al.
Publicado: (2021)

Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2022)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
por: Trier, Nicole H., et al.
Publicado: (2019)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
por: Van Steendam, Katleen, et al.
Publicado: (2011)

Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
por: Martin, Myriam, et al.
Publicado: (2023)

Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-α, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors
por: Vázquez-Del Mercado, Mónica, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1o5a5km22c2v3n941nsh4gdnt3